Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: EZLibra who wrote (3397)	2/9/2000 9:26:00 PM
From: Bruce Cullen	Read Replies (2) \| Respond to of 3702

On My Buy List Great insight TCLN looks to be a growing biotech company with their hands in various Cancer drug therapy and delivery methods; as well TCLN has numerous patents that provide the means to killing those tumors, TCLN also has numerous projects in the works and should see additional financing soon for their product pipeline. With my knowledge of this business I would imagine that this company will have royalties and license fees with added various cash inflow possibilities soon. I feel the fundamentals and technicals make TCLN a strong buy candidate with a risk oriented investor. Bruce Cullen sherwoodcoastsgroup.com Responsible Investors...See full disclaimers at my site. (Alays an opinion) Cheers